BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8982373)

  • 21. Functional outcomes after extended surgery for gastric cancer.
    Kurokawa Y; Sasako M; Sano T; Shibata T; Ito S; Nashimoto A; Kurita A; Kinoshita T;
    Br J Surg; 2011 Feb; 98(2):239-45. PubMed ID: 21104822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Indications for extensive lymphadenectomy in stomach cancer].
    Sigal MZ; Akhmetzianov FSh
    Vestn Khir Im I I Grek; 1985 Nov; 135(11):34-8. PubMed ID: 4095860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic gastrectomy with regional lymph node dissection for upper gastric cancer.
    Tanimura S; Higashino M; Fukunaga Y; Kishida S; Ogata A; Fujiwara Y; Osugi H
    Br J Surg; 2007 Feb; 94(2):204-7. PubMed ID: 17058319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement.
    Kunisaki C; Shimada H; Yamaoka H; Takahashi M; Ookubo K; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 2000; 47(32):586-9. PubMed ID: 10791244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of gastric cancer: anatomical borders and dissection of lymph nodes.
    van de Velde CJ; Sasako M
    Ann Chir Gynaecol; 1998; 87(1):89-98. PubMed ID: 9598247
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.
    Gunji Y; Suzuki T; Kobayashi S; Hori S; Hayashi H; Shimada H; Matsubara H; Nabeya Y; Ochiai T
    Hepatogastroenterology; 2003; 50(52):1178-82. PubMed ID: 12846009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node dissection in surgical treatment for remnant stomach cancer.
    Kunisaki C; Shimada H; Nomura M; Hosaka N; Akiyama H; Ookubo K; Moriwaki Y; Yamaoka H
    Hepatogastroenterology; 2002; 49(44):580-4. PubMed ID: 11995502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of para-aortic lymph node dissection in advanced gastric cancer.
    Kunisaki C; Shimada H; Yamaoka H; Wakasugi J; Takahashi M; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 1999; 46(28):2635-42. PubMed ID: 10522056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopy-assisted pylorus-preserving gastrectomy with quality controlled lymph node dissection in gastric cancer operation.
    Hiki N; Shimoyama S; Yamaguchi H; Kubota K; Kaminishi M
    J Am Coll Surg; 2006 Aug; 203(2):162-9. PubMed ID: 16864028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
    Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
    Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphadenectomy for gastric cancer.
    Mansfield PF
    J Clin Oncol; 2004 Jul; 22(14):2759-61. PubMed ID: 15199086
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appropriate gastric resection with lymph node dissection for early gastric cancer.
    Borie F; Plaisant N; Millat B; Hay JM; Fagniez PL;
    Ann Surg Oncol; 2004 May; 11(5):512-7. PubMed ID: 15078634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dissection): a multi-institutional retrospective study.
    Kunisaki C; Takahashi M; Fukushima T; Nagahori Y; Akiyama H; Makino H; Otsuka Y; Ono HA; Kosaka T; Takagawa R; Shimada H
    Am J Surg; 2008 Sep; 196(3):358-63. PubMed ID: 18466868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical treatment of scirrhous carcinoma of the stomach].
    Iwanaga T; Imaoka S; Furukawa H; Hiratsuka M
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2512-9. PubMed ID: 3017227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
    Douglass HO; Hundahl SA; Macdonald JS; Khatri VP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):133-55. PubMed ID: 17336241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer (Br J Surg 2005; 92: 5-13).
    de Manzoni G; Verlato GE
    Br J Surg; 2005 Jun; 92(6):784. PubMed ID: 15912487
    [No Abstract]   [Full Text] [Related]  

  • 38. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy.
    Isozaki H; Okajima K; Fujii K
    Hepatogastroenterology; 1997; 44(16):1133-6. PubMed ID: 9261612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
    Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
    J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.